June 18, 2025 – In a recent company announcement, Medison has appointed Tali Mirsky as Chief Legal and Compliance Officer. The move is part of Medison’s broader strategy to expand its global leadership team.
Tali Mirsky joins Medison from NICE, where she gained extensive experience in handling strategic global transactions, corporate governance, risk management, and compliance. Her appointment underscores Medison’s commitment to strengthening its legal and compliance functions at a time of increasing global expansion and regulatory challenges.
In addition to Mirsky’s appointment, the company also announced Shay Tamari as Chief Business Officer, who previously served at Pfizer. These strategic hires highlight Medison’s focus on enhancing its leadership capabilities to drive its business objectives forward.
Medison’s emphasis on compliance and governance is reflective of growing industry trends where legal oversight plays a crucial role in managing complex international operations. Mirsky’s legal acumen will likely be instrumental in steering these efforts while ensuring adherence to regulatory standards across all jurisdictions where Medison operates.
These leadership changes come at a crucial time for the company as it navigates the competitive pharmaceutical landscape while aiming to enhance its market position through strategic initiatives.